• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CT1
Click for more information
0.00% 0.2¢

CONSTELLATION TECHNOLOGIES LIMITED - Announcements

Market Cap $1.474M  ! watchlist Created with Sketch. Add to my watchlist

Constellation Technologies Limited is an Australia-based Internet of things (IoT) and... Constellation Technologies Limited is an Australia-based Internet of things (IoT) and digital solutions company. The Company is focused on offering solutions to market, which leverage cloud, IoT, edge-computing sensors, big data, analytics, machine learning (ML), artificial intelligence (AI) and other advanced technologies. The Company through Callisto offers a range of solutions designed to address various industry needs. These solutions include Food Safety & Compliance, Drugs & Medicine Monitoring, Cold Chain Logistics, and Asset Management. Its Gen3 IoT product line offers IoT devices that can capture critical data points across a range of applications, providing its customers with reliable and flexible solutions that support multiple communication networks and sensor customization. Its MeridianCT is a cloud-based software platform and mobile application, which enables users to have an end-to-end IoT data solution to connect, monitor and visualize their data. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CT1 Appendix 3B-AGX.AX 01/07/16
CT1 Prospectus-AGX.AX PRICE SENSITIVE01/07/16
CT1 Notice of Extraordinary General Meeting/Proxy Form-AGX.AX PRICE SENSITIVE29/06/16
CT1 Clarification - CCP presentation-AGX.AX 18/05/16
CT1 CCP Investor Presentation-AGX.AX 17/05/16
CT1 Appendix 4C - quarterly-AGX.AX PRICE SENSITIVE13/04/16
CT1 CCP Pty Limited Update24/03/16
CT1 Convertible Note update18/03/16
CT1 CCP Holdings Pty Limited Convertible Note29/02/16
CT1 Half Yearly Report and Accounts29/02/16
CT1 Appendix 4D December 2015PRICE SENSITIVE29/02/16
CT1 Company Secretary Appointment/Resignation03/02/16
CT1 Appendix 4C - quarterlyPRICE SENSITIVE29/01/16
CT1 Repatriation of China funds17/12/15
CT1 Change of Registered Office30/11/15
CT1 Change in substantial holding02/11/15
CT1 Appendix 3Y02/11/15
CT1 Appendix 3Y02/11/15
CT1 Appendix 3Y02/11/15
CT1 Cleansing Notice02/11/15
CT1 Appendix 3B02/11/15
CT1 Results of Meeting27/10/15
CT1 Annual General Meeting Presentation27/10/15
CT1 Appendix 4C - quarterlyPRICE SENSITIVE15/10/15
CT1 Becoming a substantial holder08/10/15
CT1 Ceasing to be a substantial holder08/10/15
CT1 Notice of Annual General Meeting/Proxy Form30/09/15
CT1 Cancellation of Securities18/09/15
CT1 Appendix 4G Corporate Governance Statement31/08/15
CT1 Annual Report to shareholders31/08/15
CT1 Appendix 4EPRICE SENSITIVE31/08/15
CT1 Update on OKS SettlementPRICE SENSITIVE27/07/15
CT1 Appendix 4C - quarterlyPRICE SENSITIVE27/07/15
CT1 Lapse of Options01/07/15
CT1 Initial Director's Interest Notice05/06/15
CT1 Final Director's Interest Notice01/06/15
CT1 Director Appointment/Resignation01/06/15
CT1 Change in substantial holding22/05/15
CT1 Cleansing Notice14/05/15
CT1 Appendix 3B12/05/15
CT1 Results of Extraordinary General Meeting12/05/15
CT1 EGM Presentation12/05/15
CT1 Appendix 4C - quarterlyPRICE SENSITIVE21/04/15
CT1 Letter to Shareholders to accompany notice of EGM13/04/15
CT1 Notice of Extraordinary General Meeting/Proxy Form13/04/15
CT1 Settlement of WritPRICE SENSITIVE12/03/15
CT1 Half Yearly Report and Accounts27/02/15
CT1 Appendix 4D Preliminary Half Year ReportPRICE SENSITIVE27/02/15
CT1 Change in substantial holding12/02/15
CT1 Appendix 3B10/02/15
CT1 Appendix 4C - quarterlyPRICE SENSITIVE12/01/15
CT1 Notice of Unserved Writ24/12/14
CT1 Becoming a substantial holder02/12/14
CT1 Final Director's Interest Notice12/11/14
CT1 Results of Annual General Meeting12/11/14
CT1 Annual General Meeting Presentation12/11/14
CT1 Appendix 4C - quarterlyPRICE SENSITIVE17/10/14
CT1 Notice of Annual General Meeting/Proxy Form03/10/14
CT1 Annual Report to shareholders29/08/14
CT1 Preliminary Final ReportPRICE SENSITIVE29/08/14
CT1 Agenix receives over $AUD 2 Million on sale of AGX 1009PRICE SENSITIVE11/08/14
CT1 Appendix 4C - quarterlyPRICE SENSITIVE31/07/14
CT1 +Agenix completes Tyrian licence acquisitionPRICE SENSITIVE04/06/14
CT1 Cleansing Notice04/06/14
CT1 Appendix 3B04/06/14
CT1 Release of Securities from Voluntary Escrow23/05/14
CT1 Agenix sells AGX 1009 for $USD 2 Million to CinkatePRICE SENSITIVE19/05/14
CT1 Appendix 4C - quarterlyPRICE SENSITIVE30/04/14
CT1 Share Registry Change of Address22/04/14
CT1 Cleansing Notice02/04/14
CT1 Appendix 3B02/04/14
CT1 Half Year Accounts28/02/14
CT1 Appendix 4DPRICE SENSITIVE28/02/14
CT1 Appendix 4C - quarterlyPRICE SENSITIVE31/01/14
CT1 Cleansing Notice28/01/14
CT1 Appendix 3B28/01/14
CT1 Key Patent granted in CanadaPRICE SENSITIVE16/01/14
CT1 Response to ASX Price QueryPRICE SENSITIVE14/01/14
CT1 Lapse of Unlisted Options27/12/13
CT1 Cleansing Notice22/11/13
CT1 Appendix 3B22/11/13
CT1 Lapse of Options22/11/13
CT1 Appendix 4C - quarterlyPRICE SENSITIVE31/10/13
CT1 Results of Meeting31/10/13
CT1 Chairman's Address to Shareholders31/10/13
CT1 Agenix sells AGX-1009PRICE SENSITIVE31/10/13
CT1 Key Patent Granted in ChinaPRICE SENSITIVE08/10/13
CT1 Replacement of Chairman and Legal Representative in China08/10/13
CT1 Cleansing Notice01/10/13
CT1 Appendix 3B01/10/13
CT1 Notice of Annual General Meeting/Proxy Form23/09/13
CT1 Annual Report to shareholders17/09/13
CT1 Appendix 4E Preliminary Final ResultsPRICE SENSITIVE29/08/13
CT1 Agenix inks co-operation agreement with ArrayjetPRICE SENSITIVE27/08/13
CT1 Change in substantial holding05/08/13
CT1 Cleansing Notice02/08/13
CT1 Appendix 3B02/08/13
CT1 Quarterly Update - July 201323/07/13
CT1 Appendix 4C - quarterlyPRICE SENSITIVE23/07/13
CT1 Change in substantial holding23/07/13
CT1 Appendix 3B-AGX.AX
01/07/16
CT1 Prospectus-AGX.AX
01/07/16PRICE SENSITIVE
CT1 Notice of Extraordinary General Meeting/Proxy Form-AGX.AX
29/06/16PRICE SENSITIVE
CT1 Clarification - CCP presentation-AGX.AX
18/05/16
CT1 CCP Investor Presentation-AGX.AX
17/05/16
CT1 Appendix 4C - quarterly-AGX.AX
13/04/16PRICE SENSITIVE
CT1 CCP Pty Limited Update
24/03/16
CT1 Convertible Note update
18/03/16
CT1 CCP Holdings Pty Limited Convertible Note
29/02/16
CT1 Half Yearly Report and Accounts
29/02/16
CT1 Appendix 4D December 2015
29/02/16PRICE SENSITIVE
CT1 Company Secretary Appointment/Resignation
03/02/16
CT1 Appendix 4C - quarterly
29/01/16PRICE SENSITIVE
CT1 Repatriation of China funds
17/12/15
CT1 Change of Registered Office
30/11/15
CT1 Change in substantial holding
02/11/15
CT1 Appendix 3Y
02/11/15
CT1 Appendix 3Y
02/11/15
CT1 Appendix 3Y
02/11/15
CT1 Cleansing Notice
02/11/15
CT1 Appendix 3B
02/11/15
CT1 Results of Meeting
27/10/15
CT1 Annual General Meeting Presentation
27/10/15
CT1 Appendix 4C - quarterly
15/10/15PRICE SENSITIVE
CT1 Becoming a substantial holder
08/10/15
CT1 Ceasing to be a substantial holder
08/10/15
CT1 Notice of Annual General Meeting/Proxy Form
30/09/15
CT1 Cancellation of Securities
18/09/15
CT1 Appendix 4G Corporate Governance Statement
31/08/15
CT1 Annual Report to shareholders
31/08/15
CT1 Appendix 4E
31/08/15PRICE SENSITIVE
CT1 Update on OKS Settlement
27/07/15PRICE SENSITIVE
CT1 Appendix 4C - quarterly
27/07/15PRICE SENSITIVE
CT1 Lapse of Options
01/07/15
CT1 Initial Director's Interest Notice
05/06/15
CT1 Final Director's Interest Notice
01/06/15
CT1 Director Appointment/Resignation
01/06/15
CT1 Change in substantial holding
22/05/15
CT1 Cleansing Notice
14/05/15
CT1 Appendix 3B
12/05/15
CT1 Results of Extraordinary General Meeting
12/05/15
CT1 EGM Presentation
12/05/15
CT1 Appendix 4C - quarterly
21/04/15PRICE SENSITIVE
CT1 Letter to Shareholders to accompany notice of EGM
13/04/15
CT1 Notice of Extraordinary General Meeting/Proxy Form
13/04/15
CT1 Settlement of Writ
12/03/15PRICE SENSITIVE
CT1 Half Yearly Report and Accounts
27/02/15
CT1 Appendix 4D Preliminary Half Year Report
27/02/15PRICE SENSITIVE
CT1 Change in substantial holding
12/02/15
CT1 Appendix 3B
10/02/15
CT1 Appendix 4C - quarterly
12/01/15PRICE SENSITIVE
CT1 Notice of Unserved Writ
24/12/14
CT1 Becoming a substantial holder
02/12/14
CT1 Final Director's Interest Notice
12/11/14
CT1 Results of Annual General Meeting
12/11/14
CT1 Annual General Meeting Presentation
12/11/14
CT1 Appendix 4C - quarterly
17/10/14PRICE SENSITIVE
CT1 Notice of Annual General Meeting/Proxy Form
03/10/14
CT1 Annual Report to shareholders
29/08/14
CT1 Preliminary Final Report
29/08/14PRICE SENSITIVE
CT1 Agenix receives over $AUD 2 Million on sale of AGX 1009
11/08/14PRICE SENSITIVE
CT1 Appendix 4C - quarterly
31/07/14PRICE SENSITIVE
CT1 +Agenix completes Tyrian licence acquisition
04/06/14PRICE SENSITIVE
CT1 Cleansing Notice
04/06/14
CT1 Appendix 3B
04/06/14
CT1 Release of Securities from Voluntary Escrow
23/05/14
CT1 Agenix sells AGX 1009 for $USD 2 Million to Cinkate
19/05/14PRICE SENSITIVE
CT1 Appendix 4C - quarterly
30/04/14PRICE SENSITIVE
CT1 Share Registry Change of Address
22/04/14
CT1 Cleansing Notice
02/04/14
CT1 Appendix 3B
02/04/14
CT1 Half Year Accounts
28/02/14
CT1 Appendix 4D
28/02/14PRICE SENSITIVE
CT1 Appendix 4C - quarterly
31/01/14PRICE SENSITIVE
CT1 Cleansing Notice
28/01/14
CT1 Appendix 3B
28/01/14
CT1 Key Patent granted in Canada
16/01/14PRICE SENSITIVE
CT1 Response to ASX Price Query
14/01/14PRICE SENSITIVE
CT1 Lapse of Unlisted Options
27/12/13
CT1 Cleansing Notice
22/11/13
CT1 Appendix 3B
22/11/13
CT1 Lapse of Options
22/11/13
CT1 Appendix 4C - quarterly
31/10/13PRICE SENSITIVE
CT1 Results of Meeting
31/10/13
CT1 Chairman's Address to Shareholders
31/10/13
CT1 Agenix sells AGX-1009
31/10/13PRICE SENSITIVE
CT1 Key Patent Granted in China
08/10/13PRICE SENSITIVE
CT1 Replacement of Chairman and Legal Representative in China
08/10/13
CT1 Cleansing Notice
01/10/13
CT1 Appendix 3B
01/10/13
CT1 Notice of Annual General Meeting/Proxy Form
23/09/13
CT1 Annual Report to shareholders
17/09/13
CT1 Appendix 4E Preliminary Final Results
29/08/13PRICE SENSITIVE
CT1 Agenix inks co-operation agreement with Arrayjet
27/08/13PRICE SENSITIVE
CT1 Change in substantial holding
05/08/13
CT1 Cleansing Notice
02/08/13
CT1 Appendix 3B
02/08/13
CT1 Quarterly Update - July 2013
23/07/13
CT1 Appendix 4C - quarterly
23/07/13PRICE SENSITIVE
CT1 Change in substantial holding
23/07/13
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $1.474M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
31 23495490 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 222518 2
View Market Depth
Last trade - 16.12pm 25/11/2024 (20 minute delay) ?
CT1 (ASX) Chart

Top Stories

ASX Market Open: Bessent hype, Lebanon ceasefire hopes push Aus markets higher | November 26, 2024

A rollercoaster ride in on Wall Street @ capped by a Dow Jones record @ and reports of an impending Israel-Hezbollah ceasefire have both buoyed Australian futures, with the ASX 200 expected to rise 0.17% at open today.Forget @Trump trade;” the U.S. rally has been super-charg...
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.